Development of colonic adenocarcinomas in a mouse model of ulcerative colitis

Inflammatory Bowel Diseases

Volumn 4, Issue 3, 1998, Pages 196-202

  Shah, Samir A ^a,b   Simpson, Stephen J ^a   Brown, Lawrence F ^a   Comiskey, Martina ^a   De Long, Ype P ^a   Allen, Deborah ^a   Terhorst, Cox ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Cd4+ T cell; Inflammatory bowel disease (IBD); Interferon; Interleukin 2; Ulcerative colitis; 2 Microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; INTERLEUKIN 2;

ADENOCARCINOMA; ANIMAL; ARTICLE; COLON TUMOR; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE MUTANT; MUTATION; PATHOLOGY; REPRODUCIBILITY; T LYMPHOCYTE; ULCERATIVE COLITIS;

ADENOCARCINOMA; ANIMALS; BETA 2-MICROGLOBULIN; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MUTATION; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES;

EID: 0032135668     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199808000-00004     Document Type: Article

References (25)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325:928-37, 1008-16.
2. Goldman H. Significance and detection of dysplasia in chronic colitis. Cancer 1996;78(11):2261-3.
3. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35(11):1590-2.
4. Hardcastle JD, Justin TA. Screening high-risk groups for colorectal neoplasia. Am J Gastroenterol 1996;91(5):850-2.
5. Itzkowitz SH, Greenwald B, Meltzer SJ. Colon cancer in inflammatory bowel disease. Inflammatory Bowel Diseases 1995;1:142-58.
6. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases 1995;24(3):475-503.
7. Bhan AK, Mizoguchi E, Mizoguchi A. New models of chronic intestinal inflammation. Curr Opin Gastroenterol 1994;10:633-8.
8. Sartor RB. Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis. Inflammatory Bowel Diseases 1995;1(1):64-75.
9. Simpson SJ, Hollander GA, Mizoguchi E, Bhan AK, Wang B, Terhorst C. Defects in T-cell regulation: lessons for inflammatory bowel disease. In: Kagnoff MF, Kiyono H, eds. Essentials of mucosal immunology. San Diego: Academic Press, 1996:291-304.
10. Sadlack B, Mėrz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75(2):253-61.
11. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75(2): 263-74.
12. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359(6397):693-9.
13. + T cells induce or protect from chronic intestinal inflammation in CB-17 scid mice. Int Immunol 1993;5(11):1461-71.
14. Hollander GA, Simpson SJ, Mizoguchi E, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995;3(1):273-8.
15. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25(9):2618-25.
16. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75(2):274-82.
17. H1-like responses. J Clin Invest 1996;98(4):1010-20.
18. + T cells. Immunity 1994;1:553-62.
19. Bicknell DC, Kaklamanis L, Hampson R, Bodmer WF, Karran P. Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 1996;6(12):1695-7.
20. Bicknell DC, Rowan A, Bodmer WF. Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. Proc Natl Acad Sci USA 1994;91(11):4751-6.
21. Ilyas M, Forbes A, Talbot IC. Mismatch repair function and neoplasia in ulcerative colitis. Gastroenterology 1996;110(4):1322-3.
22. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270(5239):1203-7.
23. Rudolph U, Finegold MJ, Rich SS, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2- deficient mice. Nat Genet 1995;10(2):143-50.
24. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 1993;119(9):549-54.
25. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112(1):29-32.